bioAffinity Technologies (BIAF) Short term Debt (2022 - 2023)
bioAffinity Technologies (BIAF) posted quarterly Short term Debt of $42334.0 for Q2 2023, down 74.87% quarter-over-quarter from $168430.0 in Q1 2023.
bioAffinity Technologies (BIAF) Short term Debt (2022 - 2023) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Short term Debt for 2 consecutive years, with $42334.0 the latest figure, recorded in Q2 2023.
- In Q2 2023, Short term Debt changed N/A year-over-year to $42334.0; the TTM figure through Jun 2023 stood at $42334.0 (changed N/A YoY), while the FY2022 annual figure was $251746.0, changed N/A from the prior year.
- Short term Debt declined to $42334.0 in Q2 2023 per BIAF's latest filing, from $168430.0 in the prior quarter.
- Across five years, Short term Debt topped out at $500000.0 in Q3 2022 and bottomed at $42334.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | bioAffinity Technologies | 1.78 Mn | -649,139.45 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 42,334.00 |
| Mar 31, 2023 | 168,430.00 |
| Dec 31, 2022 | 251,746.00 |
| Sep 30, 2022 | 500,000.00 |